Pembagian
Histologis
A. Adenoma
1.
Pleomorf
adenoma
(mixed
tumor)
2.
Monomorf
adenoma:
-‐
adenolymphoma
-‐
oksifil
adenoma
-‐
tipe
lain
B. Tumor
mukoepidermoid
C. Tumor
sel
asinus
D. Karsinoma
1.
Adenoid
kistik
karsinoma
(cylindroma)
2.
Adenokarsinoma
3.
Epidermoid
karsinoma
4.
Karsinoma
tidak
berdeferensiasi
(Undiff
Ca)
5.
Karsinoma
dalam
pleomorf
adenoma
Classification of Benign Primary Epithelial Salivary
Gland Tumors
o Mixed tumor (pleomorphic adenoma)
o Warthin tumor (papillary cystadenoma lymphomatosum)
o Oncocytoma
o Monomorphic tumors
o Sebaceous tumors
o Benign lymphoepithelial lesion
o Papillary ductal adenoma (papilloma)
o Unclassified
Penatalaksana:
1.
Kista
Parotis
-‐
ekstirpasi
batu
-‐
superficial
parotidectomy
2.
Neoplasma
-‐Superficial
Parotidectomy
VC
Jinak
Ganas
Stop
Total
Parotidectomy
(N
VII
diselamatkan)
Lnn
Subdigastricus
+
Radical
Neck
Dissection
-‐
Radioterapi
pasca
bedah
bila:
-‐
radikalitas
diragukan
-‐
high
grade
malignancy
kecuali
–
karsinoma
mukoepidermoid
-‐
tumor
sel
asinus
Tumor
ganas
parotis
inoperabel
-‐ Biopsi
-‐ Radioterapi
A.
Intraoperatif
-‐
lesi
N
VII
dan
cabangnya-‐-‐-‐lakukan
penyambungan
Hati
hati:
ramus
zygomaticus-‐-‐-‐-‐mata
ramus
buccalis-‐-‐-‐-‐-‐mulut
B.
Post
Operasi
1.
Early
a.
Facial
palsy-‐-‐-‐recovery
dalam
6-‐8minggu
b.
Perdarahan—reopen
c.
Hematom-‐-‐-‐-‐evakuasi
d.
Fistel
-‐-‐-‐-‐7-‐10
hari
menutup
dengan
bebat
tekan
e.
Sensibilitas
hilang-‐-‐-‐recovery
lebih
kurang
1
tahun
2.
Late
a.
Frey’s
Syndrome
-‐
jarang
-‐
waktu
makan
–sekitar
telinga
berkeringat
&
nyeri
-‐
crossed
innervation—serat
N
Auriculotemporalis
(parasimpatis)
dan
serat
saraf
cutan.
terapi
:
pemotongan
N
Auriculotemporalis
dekat
vasa
temporalis.
b.
Xerostomia
c.
Recurrence
karena
adanya
tumor
yang
berbentuk
hartel
Scott
A.
Laurie
and
Lisa
Licitra
.
J
Clin
Oncol
24:2673-‐2678.
©
2006
by
American
Society
of
Clinical
Oncology
TARGETED THERAPY
Scott
A.
Laurie
and
Lisa
Licitra
.
J
Clin
Oncol
24:2673-‐2678.
©
2006
by
American
Society
of
Clinical
Oncology
Amirlak
B,
emedicine
2011
Surveillance must continue indefinitely, as local
recurrence or distant metastases may become apparent many
years after the initial treatment
Physical exam:
Year 1, every 1–3 mo
Year 2, every 2–4 mo
Years 3–5, every 4–6 mo
> 5 yr, every 6–12 mo
TSH every 6-12 mo, if neck irradiated
Chest imaging as clinically indicate
NCCN 2009